Histology
Adenocarcinoma
CI-CAN-00000403Explore in graph →
2,753 active trials43 approved drugs423 evidence items
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00000403Explore in graph →
Clinical trials
9,703 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,319)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03722875 | SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery | unknown | N/A | 45 | Shanghai Zhongshan HospitalOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT03777475 | the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma | unknown | N/A | 350 | Sun Yat-sen UniversityOTHER | 1 | Dec 17, 2018 | clinicaltrials |
| NCT03775928 |
| Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer |
| unknown |
| Phase 2 |
| 80 |
| Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER |
| 1 |
| Dec 14, 2018 |
| clinicaltrials |
| NCT03673423 | Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer(OBTCPAN) | unknown | — | 138 | Ospedale San RaffaeleOTHER | 1 | Dec 13, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT02719782 | A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation | unknown | Phase 1 | 10 | Lion TCR Pte. Ltd.INDUSTRY | 1 | Nov 16, 2018 | clinicaltrials |
| NCT03732547 | Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 60 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 16, 2018 | clinicaltrials |
| NCT03742869 | HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma | unknown | — | 40 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03739164 | Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)(TAMLAPS) | unknown | — | 10 | Florida Hospital Tampa Bay DivisionOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT03734614 | Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma | unknown | — | 260 | RenJi HospitalOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT03722628 | The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC | unknown | — | 200 | Assiut UniversityOTHER | 0 | Oct 29, 2018 | clinicaltrials |
| NCT03668158 | Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma | unknown | — | 500 | Zhejiang UniversityOTHER | 0 | Oct 24, 2018 | clinicaltrials |
| NCT03708705 | Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective Study | unknown | — | 500 | Zhejiang UniversityOTHER | 0 | Oct 19, 2018 | clinicaltrials |
| NCT03630692 | Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs(TOPTACOS) | unknown | — | 158 | Institut Cancerologie de l'OuestOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT03692533 | Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma | unknown | N/A | 80 | Assiut UniversityOTHER | 0 | Oct 2, 2018 | clinicaltrials |
| NCT03692689 | Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer | unknown | Phase 2 | 30 | Sinocelltech Ltd.INDUSTRY | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03687853 | Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery | unknown | N/A | 80 | Peking University Third HospitalOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT03684863 | Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy | unknown | Phase 2 | 200 | Shandong Cancer Hospital and InstituteOTHER | 0 | Sep 26, 2018 | clinicaltrials |
| NCT02743065 | HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China(SUPER-China) | unknown | — | 100 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Sep 20, 2018 | clinicaltrials |
| NCT02005965 | Low Rectal Cancer Study (MERCURY II)(MERCURY II) | unknown | — | 542 | Royal Marsden NHS Foundation TrustOTHER | 3 | Sep 18, 2018 | clinicaltrials |
| NCT03411187 | Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy | unknown | N/A | 100 | Bo Wang,MDOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03454477 | Comparison Between Robotic, Endoscopic and Traditional Open Surgery in Thyroidectomy | unknown | N/A | 90 | Fujian Medical UniversityOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03672305 | Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC | unknown | Early Phase 1 | 50 | The Second Hospital of Nanjing Medical UniversityOTHER | 0 | Sep 18, 2018 | clinicaltrials |
| NCT01037049 | Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks | unknown | Phase 2 | 237 | Royal Marsden NHS Foundation TrustOTHER | 4 | Sep 17, 2018 | clinicaltrials |
| NCT01995942 | Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial(MARVEL) | unknown | — | 246 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT03005756 | Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma Patients(NGR) | unknown | N/A | 20 | Asan Medical CenterOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03661671 | Application of Linked Color Imaging（LCI） in Diagnosis of Early Gastric Cancer(EGC) | unknown | N/A | 2,400 | Changhai HospitalOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT03050047 | A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 15 | BiocadINDUSTRY | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03652896 | Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma | unknown | N/A | 60 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 29, 2018 | clinicaltrials |
| NCT03639662 | Psychological Impact of a Sophrological Accompaniment During the Announcement of Thyroid Cancer | unknown | N/A | 232 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT02293850 | Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma | unknown | Phase 1 | 18 | Oncolys BioPharma IncINDUSTRY | 2 | Aug 20, 2018 | clinicaltrials |
| NCT03636685 | Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC | unknown | Phase 1 / Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 0 | Aug 17, 2018 | clinicaltrials |
| NCT03632746 | Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients | unknown | — | 80 | Zhaode Bu, MDOTHER | 1 | Aug 15, 2018 | clinicaltrials |
| NCT02919878 | Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer | unknown | Phase 2 | 25 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT02919371 | Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) | unknown | Phase 1 / Phase 2 | 77 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT02525068 | A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC(RE-AKT) | unknown | Phase 2 | 136 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT02138981 | Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 4 | 436 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 3 | 252 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03609151 | Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma | unknown | N/A | 110 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT03609268 | Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma | unknown | N/A | 110 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT03594929 | Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery | unknown | N/A | 50 | Singapore General HospitalOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT03591666 | A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas | unknown | Phase 2 | 51 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Jul 19, 2018 | clinicaltrials |
| NCT02125240 | Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma(ICWIP) | unknown | Phase 3 | 124 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 16, 2018 | clinicaltrials |
| NCT02980536 | cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China | unknown | — | 129 | Berry Genomics Co., Ltd.INDUSTRY | 1 | Jul 11, 2018 | clinicaltrials |
| NCT02678806 | Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion(RHCC:BCLC-A) | unknown | N/A | 620 | Guangxi Medical UniversityOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03570502 | Incidence of POPF in the Resection of the Left Pancreas With RFAT(RFATPancreas) | unknown | — | 38 | Hospital del MarOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT03129685 | Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma(NRU) | unknown | N/A | 12 | The National Ribat UniversityOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT03551444 | Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial(CAUTIOUS) | unknown | Phase 3 | 80 | Ain Shams UniversityOTHER | 1 | Jun 11, 2018 | clinicaltrials |
| NCT01681446 | Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression | unknown | Phase 3 | 296 | Fudan UniversityOTHER | 1 | Jun 1, 2018 | clinicaltrials |
| NCT03543397 | MRI in Ductal Carcinoma in Situ (DCIS) | unknown | — | 74 | University Hospital, Strasbourg, FranceOTHER | 1 | Jun 1, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Dec 19, 2018source: clinicaltrials